|
1
|
Feinberg AP, Ohlsson R and Henikoff S: The
epigenetic progenitor origin of human cancer. Nat Rev Genet.
7:21–33. 2006. View
Article : Google Scholar
|
|
2
|
Jones PA and Martienssen R: A blueprint
for a human epigenome project: The AACR human epigenome workshop.
Cancer Res. 65:11241–11246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bannister AJ and Kouzarides T: Regulation
of chromatin by histone modifications. Cell Res. 21:381–395. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haberland M, Montgomery RL and Olson EN:
The many roles of histone deacetylases in development and
physiology: Implications for disease and therapy. Nat Rev Genet.
10:32–42. 2009. View
Article : Google Scholar
|
|
5
|
Fraga MF, Ballestar E, Villar-Garea A,
Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S,
Petrie K, et al: Loss of acetylation at Lys16 and trimethylation at
Lys20 of histone H4 is a common hallmark of human cancer. Nat
Genet. 37:391–400. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orpinell M, Fournier M, Riss A, Nagy Z,
Krebs AR, Frontini M and Tora L: The ATAC acetyl transferase
complex controls mitotic progression by targeting non-histone
substrates. EMBO J. 29:2381–2394. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mulligan P, Yang F, Di Stefano L, Ji JY,
Ouyang J, Nishikawa JL, Toiber D, Kulkarni M, Wang Q,
Najafi-Shoushtari SH, et al: A SIRT1-LSD1 corepressor complex
regulates Notch target gene expression and development. Mol Cell.
42:689–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma P and Schultz RM: Histone deacetylase 2
(HDAC2) regulates chromosome segregation and kinetochore function
via H4K16 deacetylation during oocyte maturation in mouse. PLoS
Genet. 9:e10033772013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith ER, Cayrou C, Huang R, Lane WS, Côté
J and Lucchesi JC: A human protein complex homologous to the
Drosophila MSL complex is responsible for the majority of histone
H4 acetylation at lysine 16. Mol Cell Biol. 25:9175–9188. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai Y, Jin J, Swanson SK, Cole MD, Choi
SH, Florens L, Washburn MP, Conaway JW and Conaway RC: Subunit
composition and substrate specificity of a MOF-containing histone
acetyltransferase distinct from the male-specific lethal (MSL)
complex. J Biol Chem. 285:4268–4272. 2010. View Article : Google Scholar :
|
|
11
|
Mendjan S, Taipale M, Kind J, Holz H,
Gebhardt P, Schelder M, Vermeulen M, Buscaino A, Duncan K, Mueller
J, et al: Nuclear pore components are involved in the
transcriptional regulation of dosage compensation in Drosophila.
Mol Cell. 21:811–823. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma GG, So S, Gupta A, Kumar R, Cayrou
C, Avvakumov N, Bhadra U, Pandita RK, Porteus MH, Chen DJ, et al:
MOF and histone H4 acetylation at lysine 16 are critical for DNA
damage response and double-strand break repair. Mol Cell Biol.
30:3582–3595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carrozza MJ, Utley RT, Workman JL and Côté
J: The diverse functions of histone acetyltransferase complexes.
Trends Genet. 19:321–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta A, Guerin-Peyrou TG, Sharma GG, Park
C, Agarwal M, Ganju RK, Pandita S, Choi K, Sukumar S, Pandita RK,
et al: The mammalian ortholog of Drosophila MOF that acetylates
histone H4 lysine 16 is essential for embryogenesis and
oncogenesis. Mol Cell Biol. 28:397–409. 2008. View Article : Google Scholar :
|
|
15
|
Song JS, Chun SM, Lee JY, Kim DK, Kim YH
and Jang SJ: The histone acetyltransferase hMOF is overexpressed in
non-small cell lung carcinoma. Korean J Pathol. 45:386–396. 2011.
View Article : Google Scholar
|
|
16
|
Zhao L, Wang DL, Liu Y, Chen S and Sun FL:
Histone acetyltransferase hMOF promotes S phase entry and
tumorigenesis in lung cancer. Cell Signal. 25:1689–1698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pfister S, Rea S, Taipale M, Mendrzyk F,
Straub B, Ittrich C, Thuerigen O, Sinn HP, Akhtar A and Lichter P:
The histone acetyltransferase hMOF is frequently downregulated in
primary breast carcinoma and medulloblastoma and constitutes a
biomarker for clinical outcome in medulloblastoma. Int J Cancer.
122:1207–1213. 2008. View Article : Google Scholar
|
|
18
|
Liu N, Zhang R, Zhao X, Su J, Bian X, Ni
J, Yue Y, Cai Y and Jin J: A potential diagnostic marker for
ovarian cancer: Involvement of the histone acetyltransferase, human
males absent on the first. Oncol Lett. 6:393–400. 2013.PubMed/NCBI
|
|
19
|
Wang Y, Zhang R, Wu D, Lu Z, Sun W, Cai Y,
Wang C and Jin J: Epigenetic change in kidney tumor: Downregulation
of histone acetyltransferase MYST1 in human renal cell carcinoma. J
Exp Clin Cancer Res. 32:82013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao L, Zhu L, Yang J, Su J, Ni J, Du Y,
Liu D, Wang Y, Wang F, Jin J, et al: Correlation of low expression
of hMOF with clinicopathological features of colorectal carcinoma,
gastric cancer and renal cell carcinoma. Int J Oncol. 44:1207–1214.
2014.PubMed/NCBI
|
|
21
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
22
|
Kang C, Song JJ, Lee J and Kim MY:
Epigenetics: An emerging player in gastric cancer. World J
Gastroenterol. 20:6433–6447. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; Chicago, IL: 2010
|
|
24
|
Kang ZH, Wang CY, Zhang WL, Zhang JT, Yuan
CH, Zhao PW, Lin YY, Hong S, Li CY and Wang L: Histone deacetylase
HDAC4 promotes gastric cancer SGC-7901 cells progression via p21
repression. PLoS One. 9:e988942014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fermento ME, Gandini NA, Salomón DG,
Ferronato MJ, Vitale CA, Arévalo J, López Romero A, Nuñez M, Jung
M, Facchinetti MM, et al: Inhibition of p300 suppresses growth of
breast cancer. Role of p300 subcellular localization. Exp Mol
Pathol. 97:411–424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan EM, Chan RJ, Comer EM, Goulet RJ III,
Crean CD, Brown ZD, Fruehwald AM, Yang Z, Boswell HS, Nakshatri H,
et al: MOZ and MOZ-CBP cooperate with NF-kappaB to activate
transcription from NF-kappaB-dependent promoters. Exp Hematol.
35:1782–1792. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xia J, Zhou Y, Ji H, Wang Y, Wu Q, Bao J,
Ye F, Shi Y and Bu H: Loss of histone deacetylases 1 and 2 in
hepatocytes impairs murine liver regeneration through Ki67
depletion. Hepatology. 58:2089–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Neal KC, Pannuti A, Smith ER and Lucchesi
JC: A new human member of the MYST family of histone acetyl
transferases with high sequence similarity to Drosophila MOF.
Biochim Biophys Acta. 1490:170–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hajji N, Wallenborg K, Vlachos P,
Füllgrabe J, Hermanson O and Joseph B: Opposing effects of hMOF and
SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase
II inhibitor etoposide. Oncogene. 29:2192–2204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noguchi A, Kikuchi K, Zheng H, Takahashi
H, Miyagi Y, Aoki I and Takano Y: SIRT1 expression is associated
with a poor prognosis, whereas DBC1 is associated with favorable
outcomes in gastric cancer. Cancer Med. 3:1553–1561. 2014.
View Article : Google Scholar : PubMed/NCBI
|
